title: Preventing Acquired Resistance to Bedaquiline and Delamanid in Multidrug-Resistant Tuberculosis Treatment Requires Optimal Management.
authors: 1 Centre Hospitalier de Bligny Briis-sous-Forges, France.|2 Pierre and Marie Curie University Paris, France.|3 INSERM U1135 Paris, France.
authors: Lorenzo
authors: 0000-0003-0886-9635
authors: L
authors: Guglielmetti
authors: 1 Centre Hospitalier de Bligny Briis-sous-Forges, France.
authors: Damien
authors: D
authors: Le Dû
authors: 1 Centre Hospitalier de Bligny Briis-sous-Forges, France.
authors: Mathilde
authors: M
authors: Fréchet-Jachym
authors: 4 Harvard Medical School Boston, Massachusetts.|5 Partners in Health Boston, Massachusetts and.|6 Brigham and Women's Hospital Boston, Massachusetts.
authors: Carole
authors: C
authors: Mitnick
mesh_terms: D000995:Antitubercular Agents; D064687:Diarylquinolines; D006801:Humans; D018088:Tuberculosis, Multidrug-Resistant
chemical_list: D000995:Antitubercular Agents; D064687:Diarylquinolines; C493870:bedaquiline